Sotalol Quantitation, Serum/Plasma
Also known as: SOTA SP
Use
This test measures the concentration of sotalol in serum or plasma. Sotalol is a non-selective beta-blocker used to treat ventricular arrhythmias and atrial fibrillation. Accurate quantification is essential for therapeutic drug monitoring, ensuring efficacious drug levels while minimizing the risk of adverse effects, such as arrhythmias or hypotension due to toxicity. This test helps clinicians adjust medication dosages appropriately based on the patient's response and drug concentration.
Special Instructions
Not provided.
Limitations
The test is not approved by the FDA, and therefore, its performance characteristics are not endorsed by the agency. The test's effectiveness for diagnosing health conditions outside the stated objective is not established. Furthermore, it requires specific handling and processing to maintain the stability of the sample, as incorrect sample handling could lead to inaccurate results. The variability in processing could also affect the quantification of sotalol levels, impacting clinical decisions.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Sotalol
Analyte
LOINC Codes
- 12416-4 - Sotalol SerPl-mCnc
- 12416-4 - Sotalol SerPl-mCnc
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Collect in Plain Red, Lavender (EDTA), or Pink (K2EDTA). Separate from cells ASAP or within 2 hours.
Storage Instructions
Refrigerated; also acceptable: Room temperature or frozen.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 weeks |
| Refrigerated | 1 month |
| Frozen | 1 month |
Other tests from different labs that may be relevant